Examples of using Subsequent infusions in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
If there are no adverse reactions, the infusion rate for subsequent infusions can be slowly increased to the maximum rate.
In the event of a true hypersensitivity reaction(in which severity of reaction increases with subsequent infusions), trastuzumab emtansine treatment must be permanently discontinued.
this difference declined after subsequent infusions.
for two hours after the start of the subsequent infusions for symptoms like fever
a half hours for the subsequent infusions.
then add 30 seconds for each subsequent infusion.
Minutes for first brew and then add 30 seconds for each subsequent infusion.
The safety and efficacy of a bolus dose of bivalirudin without the subsequent infusion has not been evaluated
An observation period of 30 to 60 minutes is recommended after each Perjeta infusion and before commencement of any subsequent infusion of trastuzumab or docetaxel see section 4.4.
If an infusion-related reaction develops later during the infusion or at a subsequent infusion further management will depend on its severity.
Permanently discontinue DARZALEX if the patient experiences a≥ Grade 3 infusion-related symptom at the subsequent infusion.
re-education in the event of reports of bolus only dosing without subsequent infusion.
IRR after resuming the first infusion or during a subsequent infusion.
The frequency of hypocalcaemia was much lower following subsequent infusions.
Subsequent infusions may need to occur in a clinical setting.
If the 60-minute infusion is well tolerated, all subsequent infusions may be administered over 30-minutes.
The first infusion of Avastin should last 90 minutes, but subsequent infusions may be given more quickly if the first infusion is tolerated well.
The incidence of infusion-related symptoms decreased substantially with subsequent infusions and is< 1% of patients by the eighth cycle of MabThera(-containing) treatment.
The first infusion should last 90 minutes, but subsequent infusions may be given over a shorter period if the first infusion has been well tolerated.
If the ninth infusion is completed without a severe ADR, the dose may be reduced to the equivalent of 50 mg prednisolone for subsequent infusions at the discretion of the physician.